Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

Elise van Mulligen*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)e254-e255
JournalThe Lancet Rheumatology
Volume6
Issue number5
DOIs
Publication statusPublished - May 2024

Cite this